Drew Hertig

@PhysInHistory He died at only 53... imagine how many languages he would have learned if he lived a full life!

Mathematician and polymath John von Neumann could speak eight languages by the age of six, including Ancient Greek and Latin. He could divide eight-digit numbers in his head at the age of six. He was familiar with differential and integral calculus by the age of eight. He entered the University of Budapest at the age of 15 and earned a degree in chemical engineering at the age of 19. He obtained his Ph.D. in mathematics from the University of Berlin at the age of 22.

@lolnarf @TeladocHub That traffic might be from bagholders looking for investor relations 😂

@TeladocHub have you seen the website traffic? teladoc + 37% and betterhelp +14 in last month $tdoc

Wait… read this again. The guy who scaled $TDOC GLP-1 program to $100M+ revenue just got highlighted publicly. $100M. Teladoc’s current market cap? ~$800M. So let’s do simple math: One vertical = ~12.5% of market cap. And that’s just GLP-1. Not mental health. Not chronic care. Not primary360. Not international. Meanwhile $TDOC trades like it’s going out of business. The market is pricing Teladoc like it has: • No growth engines • No product-market fit • No scalable revenue streams Yet one product suite alone is doing nine figures. Either: 1.GLP-1 is meaningless or 2.The stock is massively disconnected from reality I know which side I’m on.

This story is about those founders and CEOs who leverage early partnerships to create significant value with and without VC-backed financing. wix.to/a3xySdX #investment #biotech #alliances #partnerships #financing #nondilutive

Interesting timetable for loss of patent protection for the best selling drugs. The Top 3 by sales include: Humira ($14B, expired 2023), semaglutide/Ozempic/Wegovy ($18B, 2032), and Keytruda ($25B, 2028). #pharmaceuticalindustry #patentcliff biopharmadive.com/news/patent-cl…

I just published "3 Ways Artificial Intelligence Will Change Drug Development Forever" #drugdevelopment #AI link.medium.com/dfx9ctJe2Ib

Capital raised in Q1 2024 for San Diego-based life science companies tripled from same period last year—reaching 2021 levels—due in part by recent M&A activity. But will this trend continue? #SanDiego #Biotech #Funding shorturl.at/bjMR0

@jimcramer Powell is the worst fed chair in recent memory..

Powell is winning in so many places, from homes to job openings to starting salaries. That's one of the reasons this market can go higher so easily

@DesertDweller93 @uniQure_NV @alliancerm As an example, Zynteglo was approved in Aug and I believe @bluebirdbio started treating patients in December. First patient for Hemogenix might be sometime in Q2, late Q1 if things move fast

@uniQure_NV @alliancerm Hey $qure, when you say you are kicking off the week with this panel, how about you follow up with some news about Hemgenix? Has $cslly treated the first patient triggering our $100 million milestone payment?

We're excited to be back in San Francisco for #JPM23! We're kicking off the week with CEO Matt Kapusta participating in an @alliancerm State of the Industry panel exploring #genetherapy commercialization.

@ScorpionFund Gotta be $hood. Financial pyramid scheme with young founder who dropped out of Stanford

If Bernie Madoff and Elizabeth Holmes had a secret love child, it might resemble the scam we expose tomorrow at 730am. This one could be -90% faster than our $BLI short a year ago.

Data from MIA-PACA2 in vivo xenograft model supports QN-302 targeting S100P gene and downregulating expression. Dr. Arshad presented this data Tuesday at the AACR Special Conference: Pancreatic Cancer. bit.ly/3ePgbQS #orphandrug #cancerresearch #AACRpan22

As we wrap up a very productive year, Qualigen enters 2021 with significant cash resources and multiple near-term opportunities to reach important inflection points for our technology pipeline. Please read about our 2021 outlook from our CEO: ir.qualigeninc.com/news-events/pr…

@QualigenInc Congrats Shishir!

Congratulations to Shishir Sinha on his promotion to Qualigen's Vice President, Chief Operating Officer and Secretary! $QLGN #Cancer #CancerResearch finance.yahoo.com/news/qualigen-…

Dissecting diapers today! SAP is mixed with pulp forming the “core” of the diaper. We are looking at replacing propylene-derived SAPs with 100% #biobased and #biodegradable alternatives! 🌿🌎 @ Ecovia Renewables Inc. instagram.com/p/B2ziIYRBKMv/…

Thinkin about you #Mars 360cities.net/image/mars-pan…

@Hayley_Mae_86 @doddtra @ZaknafienDC Great picture!

@Viking_VKTX Great news!

Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol bit.ly/2OxzX17

Great news!

@FlyFrontier Had a bad experience with your airline after 3+ years. 10+ hours is too long to wait. No reimbursement. No customer support. Pls PM me I want to continue flying your airline.

Very excited for our team, our partners, and for the next phase in our company's development! twitter.com/EcoviaBio/stat…

@geoffhorst 😮